The “Artificial Intelligence (AI)-Driven Rare Disease Patient Finder Market Report 2025,” now available on ResearchAndMarkets.com, highlights rapid market growth driven by advancements in genomic sequencing, electronic health records, and AI collaborations. The market is projected to grow from $1.25 billion in 2024 to $1.62 billion in 2025, with a CAGR of 30.1%, and is expected to reach $4.6 billion by 2029 at a CAGR of 29.7%. Key growth drivers include multimodal data analytics, AI-enabled clinical decision support, and increased investments in patient-centric healthcare. Significant developments are anticipated in natural language processing, federated learning, and digital health innovations. The report also emphasizes the impact of telemedicine and remote patient monitoring. Major companies like UnitedHealth Group and GeneDx are at the forefront, with North America leading the market. The report provides in-depth market analysis, trends, and competitive landscape details essential for stakeholders in this evolving industry. For further information, visit ResearchAndMarkets.com.
Source link
